MarkWide Research - Global Market Intelligence Platform
Home›Industries›Healthcare›Veterinary

Veterinary Market Reports

Veterinary encompasses the prevention, diagnosis, and treatment of disease in non-human animals across companion, livestock, and exotic species segments. Practitioners and clinics deliver medical services, pharmaceuticals, and surgical interventions while producers of vaccines, diagnostics, and nutrition products supply the broader animal health vertical. Rising pet humanization, tightening antimicrobial stewardship, and shifting protein demand are redirecting capital flows toward biologics, precision livestock farming, and specialty referral networks.

128 Reports Found
Canine Parvovirus Market

The Canine Parvovirus Market sized at $487.6 Million in 2026 is forecast to scale to $1,033.07 Million by 2035, progressing at a 8.70% CAGR throughout the forecast period. Veterinary clinics across the United States are expanding parvovirus vaccination programs for companion dogs. USDA licensing requirements for modified-live canine vaccines continue to tighten potency and safety benchmarks. Demand concentrates in the United States, Brazil, and Germany as these countries maintain the largest canine populations with established veterinary infrastructure.

View More
Veterinary Disinfectants Market

The Veterinary Disinfectants Market, valued at $1.8 Billion in 2026, is projected to expand to $3.23 Billion by 2035, advancing at a 6.70% CAGR over the analysis window. Livestock biosecurity protocols are intensifying across commercial farming operations. The EU Green Deal's Farm to Fork strategy is accelerating chemical reformulation requirements. Demand is concentrating in Brazil's poultry belt and expanding dairy regions.

View More
Veterinary Progesterone Testing Market

The Veterinary Progesterone Testing Market valued at $187.4 Million in 2026 is projected to expand to $397.04 Million by 2035, advancing at a 8.70% CAGR over the analysis window. Breeding facilities are expanding adoption of quantitative progesterone monitoring for canine ovulation timing. FDA and USDA regulatory oversight of veterinary diagnostics is tightening quality standards for in-clinic hormone assays. Demand is concentrating in the United States, where premium pet care spending supports advanced reproductive services.

View More
Veterinary Wound Sprays Market

The Veterinary Wound Sprays Market valued at $187.4 Million in 2026 is projected to expand to $397.04 Million by 2035, advancing at a 8.70% CAGR over the analysis window. Companion animal clinics are expanding their use of antimicrobial and healing spray protocols. The FDA and EMA frameworks for veterinary medical devices and topical therapeutics are tightening purity and labeling requirements. Demand is concentrating in the United States, Germany, and Brazil as pet ownership rises and livestock health standards tighten.

View More
Bovine Collagen Market

The Bovine Collagen Market, valued at $4.8 Billion in 2026, is projected to expand to $10.17 Billion by 2035, advancing at a 8.70% CAGR over the analysis window. Nutraceutical companies now drive bulk procurement as clean-label formulations gain priority. The FDA and EFSA tighten sourcing documentation requirements for bovine-derived ingredients. China, Brazil, and Argentina concentrate raw material supply and early-stage processing capacity.

View More
Veterinary Point-Of-Care Diagnostics Market

The Veterinary Point-Of-Care Diagnostics Market worth $2.9 Billion as of 2026 is on track to achieve $6.51 Billion by 2035, compounding at 9.40% annually through 2035. Companion animal clinics in North America and Europe are expanding adoption of rapid diagnostic platforms. The FDA's streamlined 510(k) pathway for veterinary devices accelerates product entry. Demand concentrates in the United States, Germany, and Japan where pet insurance penetration and clinical standards are highest.

View More
Veterinary Antimicrobial Susceptibility Testing Market

The Veterinary Antimicrobial Susceptibility Testing Market valued at $385.4 Million in 2026 is projected to expand to $816.54 Million by 2035, advancing at a 8.70% CAGR over the analysis window. Veterinary clinics are scaling AST adoption to guide targeted therapy decisions. The FDA's veterinary feed directive and EU restrictions on prophylactic antibiotic use in livestock are tightening antimicrobial stewardship requirements. Demand concentrates in the United States, Germany, and China where large animal health networks and reference laboratories drive test volumes.

View More
Clonorchiasis Market

The Clonorchiasis Market valued at $187.4 Million in 2026 is projected to expand to $338.77 Million by 2035, advancing at a 6.80% CAGR over the analysis window. Public health programs in endemic river basin communities drive adoption of mass drug administration campaigns. WHO guidelines for neglected tropical diseases and praziquantel manufacturing scale-up shape treatment access. Demand concentrates across the Mekong Delta provinces of Vietnam, southern China's Guangxi Zhuang Autonomous Region, and the Korean peninsula's endemic watercress cultivation zones.

View More
Veterinary Thermography Market

The Veterinary Thermography Market sized at $18.7 Million in 2026 is forecast to scale to $49.41 Million by 2035, expanding at a 11.40% CAGR over the forecast window. Equine sports medicine represents a rapidly expanding end-use application where thermal imaging adoption is accelerating. The FDA's evolving guidance on veterinary diagnostic devices is reshaping product clearance pathways for manufacturers. Demand is concentrating in the United States, particularly across Texas and Kentucky equine corridors.

View More
Australia Veterinary Healthcare Market

The Australia Veterinary Healthcare Market valued at $2.8 Billion in 2026 is projected to expand to $5.41 Billion by 2035 advancing at a 7.60% CAGR over the analysis window. Pet owners are driving adoption of preventive care services across companion animal segments. The TGA's veterinary medicine registration framework shapes product commercialization timelines. Demand concentrates in New South Wales and Victoria where specialist veterinary hospital networks cluster.

View More
Europe Veterinary Vaccine Market

The Europe Veterinary Vaccine Market valued at $2.45 Billion in 2026 is expected to reach $4.43 Billion by 2035 growing at a CAGR of 6.80% through the forecast horizon. Companion animal clinics are expanding vaccine protocols for canine and feline patients. The EU Veterinary Medicines Regulation is streamlining approval pathways for novel immunologicals. Demand concentrates in Germany, where livestock density and pet ownership rates support high veterinary service utilization.

View More
Global Animal Intestinal Health Market

The Global Animal Intestinal Health Market valued at $6.8 Billion in 2026 is projected to expand to $14.05 Billion by 2035 advancing at a 8.40% CAGR over the analysis window. Livestock producers across commercial poultry and swine operations are intensifying adoption of microbial feed additives as antibiotic growth promoter bans tighten under EU veterinary medicinal product frameworks and US FDA guidance. Demand concentrates in China, where the national feed industry's shift toward enzyme and probiotic supplementation reshapes procurement patterns for domestic and multinational ingredient suppliers.

View More
Global Animal Vaccine Market

The Global Animal Vaccine Market valued at $12.4 Billion in 2026 is projected to expand to $23.97 Billion by 2035, advancing at a 7.60% CAGR over the analysis window. Livestock farmers in Brazil are scaling preventive immunization programs against foot-and-mouth disease. The European Medicines Agency tightened cold-chain distribution standards for thermolabile biologicals. Demand concentrates in India where government-funded national livestock health missions are widening vaccine access across dairy cooperatives.

View More
Global Canine Influenza Vaccine Market

The Global Canine Influenza Vaccine Market valued at $84.5 Million in 2026 is projected to expand to $152.76 Million by 2035, advancing at a 6.80% CAGR over the analysis window. Veterinary clinics represent the fastest-expanding end-user channel as pet owners seek preventive care for companion animals. The USDA regulates veterinary biologics under the Virus-Serum-Toxin Act, tightening potency and safety requirements. Demand concentrates in the United States, where kennel boarding mandates and show dog travel requirements sustain higher vaccination rates than in most other countries.

View More
Global Veterinary Artificial Insemination Market

The Global Veterinary Artificial Insemination Market valued at $3.4 Billion in 2026 is projected to expand to $6.91 Billion by 2035 advancing at a 8.20% CAGR over the analysis window. Dairy farmers across North America and Europe are expanding artificial insemination programs to improve herd genetics and milk yields. The EU Green Deal's sustainable agriculture mandates are accelerating demand for precision breeding technologies that reduce livestock methane emissions. Demand concentrates most intensely in the United States, where large-scale dairy operations in Wisconsin and California drive semen straw and cryopreservation equipment procurement.

View More
Global Veterinary Rapid Test Market

The Global Veterinary Rapid Test Market valued at $1.42 Billion in 2026 is forecast to scale to $2.98 Billion by 2035, progressing at a 8.60% CAGR throughout the forecast period. Companion animal clinics in Germany and France are expanding point-of-care testing menus for canine and feline infectious diseases. The EU MDR and IVDR frameworks are tightening performance documentation requirements for in vitro diagnostic reagents sold across member states. Demand concentrates most visibly in the United States, where corporate veterinary group consolidation is standardizing procurement of rapid assay platforms across multi-site clinic networks.

View More
Veterinary Antibiotics Market

The Veterinary Antibiotics Market assessed at $6.8 Billion in 2026 is forecast to scale to $11.1 Billion by 2035, progressing at a 5.60% CAGR throughout the forecast period. Livestock producers in Brazil are expanding antimicrobial stewardship programs under national agricultural ministry guidelines. Tetracycline-class products command the dominant share of prescription volumes across feedlot operations. Demand concentrates most acutely in China's intensive pork production belt spanning Sichuan, Henan, and Shandong provinces.

View More
India Veterinary Healthcare Market

The India Veterinary Healthcare Market valued at $2.8 Billion in 2026 is expected to reach $7.4 Billion by 2035 growing at a CAGR of 11.40% through the forecast horizon. Livestock farmers represent the fastest-expanding end-user base as commercial dairy and poultry operations professionalize their herd health management. India's PLI scheme for animal husbandry and pharmaceutical manufacturing incentives are reshaping domestic production capacity. Demand concentrates in Gujarat, Maharashtra, and Punjab where intensive dairy cooperatives and export-oriented poultry clusters drive bulk procurement of vaccines and feed additives.

View More
Veterinary Clostridium Vaccine Market

The Veterinary Clostridium Vaccine Market valued at $487.3 Million in 2026 is expected to reach $880.92 Million by 2035, growing at a CAGR of 6.80% through the forecast horizon. Commercial livestock operations in North America are expanding procurement of multivalent formulations following updated USDA guidelines for clostridial disease prevention. Brazil's beef export sector is concentrating demand for herd-health protocols that integrate vaccination into pre-slaughter certification programs.

View More
North America and Europe Veterinary Telehealth Market

The North America and Europe Veterinary Telehealth Market valued at $285.4 Million in 2026 is projected to expand to $1,335.09 Million by 2035 advancing at a 18.70% CAGR over the analysis window. Pet owners in suburban and rural communities represent the fastest-expanding user base as they seek alternatives to clinic travel. The FDA's evolving guidance on telemedicine prescribing authority for veterinarians is loosening operational constraints in the United States. Demand is concentrating in the United Kingdom where veterinary workforce shortages and high pet ownership rates are accelerating platform adoption.

View More
Global Animal Sedative Market

The Global Animal Sedative Market valued at $1.4 Billion in 2026 is projected to expand to $2.53 Billion by 2035, advancing at a 6.80% CAGR over the analysis window. Veterinary clinics are expanding their anesthesia protocols for companion animal dentistry and orthopedic surgery. The FDA's Center for Veterinary Medicine tightened residue monitoring for alpha-2 agonists in food-producing species. Demand concentrates in the United States, where specialty and emergency veterinary networks are consolidating procurement.

View More
Veterinary Hospitals Market

The Veterinary Hospitals Market valued at $118.4 Billion in 2026 is projected to expand to $250.85 Billion by 2035, advancing at a 8.70% CAGR over the analysis window. Pet owners now drive service volume at emergency and specialty facilities across North America and Western Europe. FDA Center for Veterinary Medicine oversight of compounded drugs and the EU Veterinary Medicines Regulation are tightening compliance requirements for hospital pharmacies. Demand concentrates in the United States, where specialty referral networks and corporate consolidation redefine how veterinary care is delivered and financed.

View More
Global Cattle Vaccines Market

The Global Cattle Vaccines Market valued at $2.4 Billion in 2026 is projected to expand to $4.34 Billion by 2035, advancing at a 6.80% CAGR over the analysis window. Dairy farm procurement is rebalancing toward preventive health programs as foot-and-mouth disease eradication mandates tighten under USDA and OIE guidelines. Demand concentrates in Brazil's Mato Grosso ranching belt, where large-scale feedlot operators are consolidating veterinary supply contracts.

View More
Mastitis Market

The Mastitis Market worth $1.8 Billion as of 2026 is on track to achieve $3.15 Billion by 2035, advancing at a 6.40% CAGR over the analysis window. Dairy farmers in commercial operations are expanding adoption of preventive herd health programs. The FDA's updated antimicrobial use guidelines for food-producing animals are reshaping treatment protocols. Demand concentrates in the United States, where large-scale dairy cooperatives drive bulk procurement of intramammary therapies.

View More
Global Animal Antimicrobials and Antibiotics Market

The Global Animal Antimicrobials and Antibiotics Market valued at $5.8 Billion in 2026 is projected to expand to $10.14 Billion by 2035, advancing at a 6.40% CAGR over the analysis window. Livestock producers in intensive poultry operations drive adoption as they confront antimicrobial resistance protocols. The EU's Veterinary Medicines Regulation restricts prophylactic use, redirecting investment toward targeted therapeutics. Demand concentrates in Brazil's integrated broiler sector, where vertical coordination accelerates veterinary pharmaceutical uptake.

View More
United Kingdom Veterinary Healthcare Market

The United Kingdom Veterinary Healthcare Market valued at $2.8 Billion in 2026 is projected to expand to $5.02 Billion by 2035, advancing at a 6.70% CAGR over the analysis window. Pet owners are driving adoption of advanced diagnostics and preventive care services. The Veterinary Medicines Directorate's updated pharmacovigilance requirements are reshaping product registration pathways. Demand concentrates in Greater London and the South East, where specialist referral hospitals and corporate practice chains cluster.

View More
Global Orthopedic Veterinary Implants Market

The Global Orthopedic Veterinary Implants Market valued at $218.5 Million in 2026 is projected to expand to $451.56 Million by 2035, advancing at a 8.40% CAGR over the analysis window. Specialty veterinary clinics are expanding orthopedic surgical capacity across developed markets. FDA and USDA regulatory frameworks are tightening biocompatibility and sterilization standards for implantable devices. Demand is concentrating in the United States, Germany, and Japan where pet insurance penetration and referral-level veterinary practice density are highest.

View More
Veterinary Endotracheal Tubes Market

The Veterinary Endotracheal Tubes Market valued at $187.4 Million in 2026 is projected to expand to $338.77 Million by 2035, advancing at a 6.80% CAGR over the analysis window. Companion animal hospitals in North America and Europe are expanding their anesthesia departments. FDA and EU MDR standards for single-use medical devices are tightening material compliance requirements. Demand concentrates in the United States and Germany where specialty veterinary referral centers cluster.

View More

Get Expert Help

Can't find what you need? Our analysts will help you locate or build the right report for your requirements.

Contact Our Team →